Neurociencias
Departamento
University of Copenhagen
Copenhague, DinamarcaPublicaciones en colaboración con investigadoras/es de University of Copenhagen (22)
2024
-
PsyCog: A computerised mini battery for assessing cognition in psychosis
Schizophrenia Research: Cognition, Vol. 37
2023
-
Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))
Nature communications
-
Impact of adverse childhood experiences on educational achievements in young people at clinical high risk of developing psychosis
European Psychiatry, Vol. 66, Núm. 1
-
Role of trazodone in treatment of major depressive disorder: an update
Annals of General Psychiatry, Vol. 22, Núm. 1
2022
-
New insights into the genetic etiology of Alzheimer's disease and related dementias
Nature genetics, Vol. 54, Núm. 4, pp. 412-436
-
Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review
European Neuropsychopharmacology, Vol. 54, pp. 90-99
-
Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis
Psychological Medicine, Vol. 52, Núm. 8, pp. 1569-1577
2021
-
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
Nature communications, Vol. 12, Núm. 1, pp. 3417
-
Corrigendum to “Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121–136]” (European Neuropsychopharmacology (2020) 36 (121–136), (S0924977X20301802), (10.1016/j.euroneuro.2020.05.006))
European Neuropsychopharmacology
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder
International Journal of Bipolar Disorders, Vol. 9, Núm. 1
2020
-
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)
Acta Neuropathologica
-
Emotion Recognition and Adverse Childhood Experiences in Individuals at Clinical High Risk of Psychosis
Schizophrenia bulletin, Vol. 46, Núm. 4, pp. 823-833
-
New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy
Brain, Vol. 143, Núm. 9, pp. 2696-2708
-
Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness
Genetics in Medicine, Vol. 22, Núm. 9, pp. 1478-1488
2019
-
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Acta Neuropathologica, Vol. 138, Núm. 2, pp. 237-250
-
Cohort profile: Design and methods of the PREDIMED-Plus randomized trial
International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 387-388o
-
Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 90, Núm. 5, pp. 576-585
2018
-
Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments
Neuroscience and Biobehavioral Reviews, Vol. 94, pp. 11-16
-
Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial
PLoS ONE, Vol. 13, Núm. 6